Karlsson D, Fallarero A, Shinde P, Anju CP, Busygin I, Leino R, Mohan CG, Vuorela P (2014)
Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase
Nat Prod Commun 9: 455
Prinz M, Parlar S, Bayraktar G, Alptuzun V, Erciyas E, Fallarero A, Karlsson D, Vuorela P, Burek M, Forster C, Turunc E, Armagan G, Yalcin A, Schiller C, Leuner K, Krug M, Sotriffer CA, Holzgrabe U (2013)
1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BCHE, and amyloid-beta aggregation crossing the blood-brain barrier
Eur J Pharm Sci 49: 603
Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P (2012)
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine
Bioorganic & Medicinal Chemistry 20: 6669
Karlsson D, Fallarero A, Brunhofer G, Guzik P, Prinz M, Holzgrabe U, Erker T, Vuorela P (2012)
Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation
Eur J Pharm Sci 45: 169
Karlsson D, Fallarero A, Brunhofer G, Mayer C, Prakash O, Mohan CG, Vuorela P, Erker T (2012)
The exploration of thienothiazines as selective butyrylcholinesterase inhibitors
Eur J Pharm Sci 47: 190
Jarvinen P, Vuorela P, Hatakka A, Fallarero A (2011)
Potency determinations of acetylcholinesterase inhibitors using Ellman's reaction-based assay in screening: Effect of assay variants
Analytical Biochemistry 408: 166
Alptuzun V, Prinz M, Horr V, Scheiber J, Radacki K, Fallarero A, Vuorela P, Engels B, Braunschweig H, Erciyas E, Holzgrabe U (2010)
Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases
Bioorganic & Medicinal Chemistry 18: 2049